Rayence Co., Ltd. (KOSDAQ:228850)

Market Cap	107.17B
Revenue (ttm)	125.56B
Net Income (ttm)	8.12B
Shares Out	15.74M
EPS (ttm)	515.81
PE Ratio	13.20
Forward PE	9.73
Dividend	100.00 (1.47%)
Ex-Dividend Date	Dec 27, 2024

Volume	4,203
Average Volume	7,427
Open	6,830.00
Previous Close	6,830.00
Day's Range	6,710.00 - 6,840.00
52-Week Range	5,620.00 - 9,320.00
Beta	0.93
RSI	60.10
Earnings Date	Feb 14, 2025

About Rayence

Rayence Co., Ltd., together with its subsidiaries, engages in the development, manufacture, and sale of digital X-ray detector products for dental, medical, veterinary, and industrial sectors in South Korea, the United States, Mexico, China, and internationally. The company offers TFT/CMOS X-ray detectors for general radiography, C-arm/RF, mammography, and radiotherapy; and CMOS/Super IGZO TFT/a-Si TFT X-ray detectors for applications, such as dental, veterinary, AXI, die-casting, 2D/3D inline/offline, pipe inspection, etc. It also provides rad...

• Industry: X-Ray Apparatus and Tubes and Related Irradiation Apparatus
• Founded: 2011
• Employees: 224
• Stock Exchange: KOSDAQ
• Ticker Symbol: 228850

Financial Performance

In 2024, Rayence's revenue was 125.56 billion, a decrease of -12.18% compared to the previous year's 142.99 billion. Earnings were 8.12 billion, a decrease of -58.59%.